Industry Perspectives
| 2 min read
The launch marks a major step toward more predictive, human-relevant drug development using microphysiological systems.
| 3 min read
The funding round will support expanded US manufacturing and accelerate the company’s enzymatic DNA synthesis technology.
| 2 min read
Collaboration integrates Agilent’s SureSelect Max DNA Library Prep Kits with SPT Labtech’s firefly+ platform, streamlining genomic sequencing with hands-free automation.
| 2 min read
The collaboration combines Celonic’s biologics expertise with Carbogen Amcis’s payload and conjugation capabilities to create a seamless, end-to-end ADC development pathway.
| 2 min read
The updated brand identity underscores nearly 30 years of scientific leadership and a growing portfolio designed for modern preclinical discovery.
| 6 min read
By combining 3D biofabrication with perfusable vasculature, researchers are paving the way for fully implantable organs.
| 3 min read
The POSEIDON program aims to create first-in-class synthetic sensor-based tests to detect over 30 cancers at Stage I using only non-invasive breath and urine samples.
| 2 min read
Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts
| 2 min read
LGC Standards reveals new 13C-labelled PFAS mixtures and single solutions to support laboratories using EPA Method 1633.
| 4 min read
The HDAC inhibitor givinostat has received regulatory approval in the US, EU, and UK for patients six years and older.
| 3 min read
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker
| 3 min read
The new diagnostic enables rapid identification of acute leukaemia patients with KMT2A rearrangements for precision therapy.
